Table 1 Demographic, Histological and Methylation Characteristics of Chordoid Meningioma
From: Epigenetic and genomic profiling of chordoid meningioma: implications for clinical management
Patient-tumor | Age/Sex | Anatomic location | Percent chordoid | WHO grade | Mits/10HPF | MIB % | EOR | PFS (mo) | Recur | MC | CNV |
|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 42/M | Frontal convexity | 100 | 1 | 0 | 7.5 | NA | 125 | No | NA | NA |
2-ut33 | 42/F | Frontal convexity | 90 | 1 | 0 | 5.0 | GTR | 232 | No | Inter-A | 1p loss, 3q gain |
3-ut34 | 46/F | Frontal falx | 70 | 1 | 0 | 0.8 | GTR | 221 | No | Ben-2 | 1p,3p,3q loss |
4-ut36 | 46/F | Frontal convexity | 100 | 1 | 0 | 0.3 | GTR | 170 | No | Ben-2 | 1p,2p,2q loss |
5-ut37 | 34/F | Sphenoid ridge | 90 | 1 | 0 | 6.4 | GTR | 66 | No | Ben-2 | No loss/gain |
6-ut38 | 54/F | Foramen magnum | 60 | 1 | 0 | 3.0 | GTR | 31 | No | Ben-2 | No loss/gain |
7-ut39 | 40/F | Frontal convexity | 90 | 1 | 0 | 2.0 | GTR | 124 | No | Ben-2 | No loss/gain |
8-ut40 | 37/F | Temporal tentorium | 100 | 1 | 0 | 0.5 | GTR | 110 | No | Ben-2 | 1p,2p loss |
9-ut41 | 66/M | Foramen magnum | 90 | 1 | 0 | 1.0 | GTR | 47 | No | Ben-2 | 1p loss |
10-ut42 | 45/F | Sphenoid ridge | 80 | 1 | 0 | 5.8 | STR | 65 | No | Ben-2 | 1p loss |
11-ut35 | 61/M | Parietal falx | 70 | 2 | 12 | 14.5 | GTR | 30 | Yes (DOD) | Mal | 1,8p,10,14,22q loss* |
12-ut43 | 50/F | Temporal tentorium | 80 | 2 | 5 | 9.2 | GTR | 38 | No | Ben-2 | 1p,2p,22q loss |